Biondo Investment Advisors, LLC Intercept Pharmaceuticals, Inc. Transaction History

Biondo Investment Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 08, 2020	SELL	$48.35 - $118.68 $2.43 Million - $5.96 Million	-50,260 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$57.36 - $124.1 $718,491 - $1.55 Million	12,526 Added 33.2%	50,260 $6.23 Million
Q3 2019 Nov 05, 2019	SELL	$58.69 - $80.46 $19,895 - $27,275	-339 Reduced 0.89%	37,734 $2.5 Million
Q2 2019 Aug 06, 2019	BUY	$77.77 - $120.68 $8,010 - $12,430	103 Added 0.27%	38,073 $3.03 Million
Q1 2019 May 08, 2019	BUY	$91.83 - $120.68 $1.65 Million - $2.17 Million	17,945 Added 89.61%	37,970 $4.25 Million
Q4 2018 Feb 08, 2019	SELL	$85.79 - $126.46 $889,642 - $1.31 Million	-10,370 Reduced 34.12%	20,025 $2.02 Million
Q3 2018 Nov 07, 2018	BUY	$88.49 - $127.55 $2.69 Million - $3.88 Million	30,395 New	30,395 $3.84 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Biondo Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Biondo Investment Advisors, LLC with notifications on news.